• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-CDK12/CRKRS

CDK12/CRKRS Polyclonal Antibody for IF, WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IF, ELISA

Conjugaison

Non conjugué

N° de cat : 26816-1-AP

Synonymes

CDC2 related protein kinase 7, CDK12, CDK12/CRKRS, CRK7, CRKR, CRKRS, KIAA0904



Applications testées

Résultats positifs en WBcellules HeLa, cellules Jurkat, cellules K-562
Résultats positifs en IFcellules HeLa

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:16000
Immunofluorescence (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

26816-1-AP cible CDK12/CRKRS dans les applications de WB, IF, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène CDK12/CRKRS Protéine recombinante Ag25323
Nom complet Cdc2-related kinase, arginine/serine-rich
Masse moléculaire calculée 1490 aa, 164 kDa
Poids moléculaire observé 180-200 kDa
Numéro d’acquisition GenBankBC150265
Symbole du gène CRKRS
Identification du gène (NCBI) 51755
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

CRKRS (Cdc2-related kinase, Arg/Ser), also named as cyclin-dependent kinase 12 (CKD12), belongs to CDC2/CDKX subfamily. CDK12 can form a heterodimeric complex with its activating partner, cyclin K, to regulate important cellular physiological processes that include transcriptional regulation, regulation of DNA damage repair genes such as BRCA1 and ATM, suppression of intronic polyadenylation, and susceptibility to PARP inhibitors (PMID: 30487607, 24240700, 31694772). CDK12 has 3 isoforms with the calculated molecular mass of 164/163/141 kDa, and the apparent molecular mass of 180-200 kDa due to some modifications (PMID 11683387, 22988298).

Protocole

Product Specific Protocols
WB protocol for CDK12/CRKRS antibody 26816-1-APDownload protocol
IF protocol for CDK12/CRKRS antibody 26816-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Eur J Cancer

CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT.

Authors - Hui Li
humanWB

iScience

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate

Authors - Mareike Polenkowski
human

Int J Med Sci

Expression pattern of CDK12 protein in gastric cancer and its positive correlation with CD8+ cell density and CCL12 expression.

Authors - Jun Ji
humanWB

Cell Death Discov

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12.

Authors - Yan Liang
  • KD Validated

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

M (Verified Customer) (06-29-2021)

No Signal at all at the right size. A couple of non specific bands showed up at lower molecular weights.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:1000
  • Cell Tissue Type: Human Liver lysate
CDK12/CRKRS Antibody Western Blot validation (1:1000 dilution) in Human Liver lysate (Cat no:26816-1-AP)